Jena Bioscience Screens

Neutral field screens

ELE7548 EACH
EUR 79.2

Human IgG antibody Laboratories manufactures the jena bioscience screens reagents distributed by Genprice. The Jena Bioscience Screens reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Jena Bioscience GmbH. Other Jena products are available in stock. Specificity: Jena Category: Bioscience Group: Screens

True north Cryobox 5mLBlue

PK10
EUR 153.6

True north Cryobox 15mLNatural

PK10
EUR 212.4

True north Cryobox 15mLBlue

PK10
EUR 212.4

True north Cryobox 50mLNatural

PK10
EUR 210

True north Cryobox 50mLBlue

PK10
EUR 210

True north Cryobox1.5/2mLNatural

PK10
EUR 162

True north Cryobox1.5/2.0mLGreen

PK10
EUR 162

Screens information

IL-23R:IL-23A[Biotin] Inhibitor Screening Assay Kit

78014 96 rxns.
EUR 1130
Description: The IL-23RA:IL-23A[Biotin] Inhibitor Screening Assay Kit is designed for screening inhibitors of IL-23A:IL-23RA interaction. The key to this kit is the high sensitivity of detection of biotin-labeled IL-23A by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, IL-23RA is coated on a 96-well plate. Next, IL-23A[Biotin] is incubated with IL-23RA on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader.

Mouse CTLA4[Biotin]:B7-1 Inhibitor Screening Assay Kit

79515 96 rxns.
EUR 1235
Description: The Mouse CTLA4[biotin]:B7-1 Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of mouse CTLA4:B7-1 signaling. This kit comes in a convenient 96-well format, with biotin-labeled mouse CTLA4, purified mouse B7-1, streptavidin-labeled HRP, and assay buffer for 100 binding reactions. The key to this kit is the high sensitivity of detection of biotin-labeled mouse CTLA4 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, B7-1 is coated on a 96-well plate. Next, CTLA4[biotin] is incubated with B7-1 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.

IL-17RA:IL-17A[Biotin] Inhibitor Screening Assay Kit

79891 96 rxns.
EUR 1245
Description: The IL-17RA:IL-17A[Biotin] Inhibitor Screening Assay Kit is designed for screening inhibitors of IL-17A:IL-17RA interaction. The key to this kit is the high sensitivity of detection of biotin-labeled IL-17A by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, IL-17RA is coated on a 96-well plate. Next, IL-17A[Biotin] is incubated with IL-17RA on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader.

IL-17RA[Biotin]:IL-17A Inhibitor Screening Assay Kit

72060 96 rxns.
EUR 1245
Description: The IL-17RA[Biotin]:IL-17A Inhibitor Screening Assay Kit is designed for_x000D_screening inhibitors of IL-17A:IL-17RA interaction. The IL-17RA[Biotin]-IL-17A Binding Assay Kit_x000D_comes in a convenient 96-well format, with biotin-labeled IL-17RA, purified IL-17A, streptavidinlabeled_x000D_HRP, and assay buffer for 100 binding reactions. The key to this kit is the high_x000D_sensitivity of detection of biotin-labeled IL-17RA by streptavidin-HRP. Only a few simple steps_x000D_on a microtiter plate are required for the assay. First, IL-17A is coated on a 96-well plate. Next,_x000D_IL-17RA is incubated with IL-17A on the plate. Finally, the plate is treated with streptavidin-HRP_x000D_followed by addition of an HRP substrate to produce chemiluminescence, which can then be_x000D_measured using a chemiluminescence reader.

PD-1[Biotinylated]: PD-L1 Inhibitor Screening Assay Kit

79523 384 rxns.
EUR 1070
Description: Cell signaling through the PD-1 receptor upon binding the PD-L1 ligand attenuates immune responses and is exploited by both tumors and viruses. The PD-1[Biotinylated]: PD-L1 Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of this signaling. This kit comes in a convenient 384-well format with biotin-labeled PD-1, purified PD-L1, streptavidin-labeled HRP, and assay buffer for 400 binding reactions. The key to this kit is the high sensitivity of detection of biotin-labeled PD-1 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, PD-L1 is coated on a 384-well plate. Next, PD-1 is incubated with PD-L1 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader.

PD-1:PD-L1[Biotinylated] Inhibitor Screening Assay Kit

72003 96 rxns.
EUR 1235
Description: The PD-1:PD-L1[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of this signaling. The key to this kit is the high sensitivity of detection of biotin-labeled PD-L1 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, PD-1 is coated on a 96-well plate. Next, PD-L1 is incubated with PD-1 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader.

PD-1:PD-L2[Biotinylated] Inhibitor Screening Assay Kit

72004 96 rxns.
EUR 1095
Description: The PD-1:PD-L2[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of this signaling. The key to this kit is the high sensitivity of detection of biotin-labeled PD-L2 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, PD-1 is coated on a 96-well plate. Next, PD-L2 is incubated with PD-1 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader.

PD-1[Biotinylated]:PD-L1 Inhibitor Screening Assay Kit

72005 96 rxns.
EUR 840
Description: The PD-L1 Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of this signaling. The key to this kit is the high sensitivity of detection of biotin-labeled PD-1 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, PD-L1 is coated on a 96-well plate. Next, PD-1 is incubated with PD-L1 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader.

PD-1[Biotinylated]:PD-L2 Inhibitor Screening Assay Kit

72006 96 rxns.
EUR 1235
Description: The PD-L2 Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of this signaling. The key to this kit is the high sensitivity of detection of biotin-labeled PD-1 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, PD-L2 is coated on a 96-well plate. Next, PD-1 is incubated with PD-L2 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader.

CD28:B7-1[Biotinylated] Inhibitor Screening Assay Kit

72007 96 rxns.
EUR 1070
Description: The CD28:B7-1[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of CD28:B7-1 signaling. The key to this kit is the high sensitivity of detection of biotin-labeled B7-1 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, CD28 is coated on a 96-well plate. Next, B7-1 is incubated with CD28 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.

PD-L1:B7-1[Biotinylated] Inhibitor Screening Assay Kit

72026 96 rxns.
EUR 1215
Description: The PD-L1:B7-1[Biotinylated] Inhibitor Screening Assay Kit is designed for_x000D_screening and profiling inhibitors of the PD-L1:B7-1 interaction. The key to this kit is the high sensitivity of detection of_x000D_biotin-labeled B7-1 by streptavidin-HRP. Only a few simple steps on a microtiter plate are_x000D_required for the assay. First, PD-L1 is coated on a 96-well plate. Next, B7-1-biotin is incubated_x000D_with PD-L1 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition_x000D_of an HRP substrate to produce chemiluminescence, which can then be measured using a_x000D_chemiluminescence reader.

CD28:B7-2[Biotinylated] Inhibitor Screening Assay Kit

72062 96 rxns.
EUR 1070
Description: The CD28:B7-2[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of CD28:B7-2 signaling. The key to this kit is the high sensitivity of detection of biotin-labeled B7-2 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, CD28 is coated on a 96-well plate. Next, B7-2 is incubated with CD28 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.

CTLA4 : B7-2[Biotinylated] Inhibitor Screening Assay Kit

79658 96 rxns.
EUR 1205
Description: The CTLA4:B7-2[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of CTLA4:B7-2-biotin interaction. The key to this kit is the high sensitivity of detection of CTLA4 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, CTLA4 is coated on a 96-well plate. Next, B7-2-biotin is incubated with CTLA4 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader.

BAFF:BCMA[Biotinylated] Inhibitor Screening Assay Kit

79667 96 rxns.
EUR 765
Description: The BAFF:BCMA[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of BAFF:BCMA signaling.The key to this kit is the high sensitivity of detection of biotin-labeled BCMA by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, BAFF is coated on a 96-well plate. Next, BCMA is incubated with BAFF on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.

CD27:CD70[Biotinylated] Inhibitor Screening Assay Kit

79695 96 rxns.
EUR 1070
Description: The CD27:CD70[Biotinylated] Inhibitor Screening Assay Kit is designed for_x000D_ screening and profiling inhibitors of CD27:CD70 signaling. This kit comes in a convenient 96- well_x000D_ format, with biotin-labeled CD70, purified CD27, streptavidin-labeled HRP, and assay buffer for_x000D_100 binding reactions. The key to this kit is the high sensitivity of detection of biotin-labeled CD70_x000D_by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay._x000D_ First, CD27 is coated on a 96-well plate. Next, CD70 is incubated with CD27 on the plate. Finally,_x000D_ the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce_x000D_ chemiluminescence, which can be measured using a chemiluminescence reader.

LAG3:FGL1[Biotinylated] Inhibitor Screening Assay Kit

79789 96 rxns.
EUR 830
Description: The LAG3:FGL1[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of LAG3:FGL1. The key to this kit is the high sensitivity of detection of biotin-labeled FGL1 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, LAG3 is attached on a nickel-coated 96-well plate. Next, biotinylated FGL1 is incubated with LAG3 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.

CTLA4 [Biotinylated]:B7-1 Inhibitor Screening Assay Kit

79973 96 rxns.
EUR 1070
Description: The activation of naíve T cells requires two signals, the specific T cell receptor recognition of MHC/Antigen on the surface of the antigen-presenting cell (APC), and the binding of B7-1 (CD80) ligand on the APC with the CD28 receptor on the T cell surface. Conversely, binding of CTLA4 to B7-1 on the T-cell surface results in an inhibitory signal and prevents T-cell activation. CTLA4B7-1 interaction is an important drug target for the regulation of the host's response to cancer. The CTLA4 [Biotinylated]:B7-1 Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of CTLA4:B7-1 signaling. The key to this kit is the high sensitivity of detection of biotin-labeled CTLA4 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, B7-1 is coated on a 96-well plate. Next, CTLA4[B] is incubated with B7-1 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.